Literature DB >> 3278578

The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetics.

M C Houston1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3278578     DOI： 10.1016/0002-8703(88)90816-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  10 in total

Review 1.  Antihypertensive drugs and incidence of type 2 diabetes: evidence and implications for clinical practice.

Authors:  Samuel Asfaha; Raj Padwal
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

2.  A cooperative study to evaluate the efficacy and safety of enalapril in Puerto Rican patients with mild to moderate hypertension.

Authors:  A Medina-Ruiz; J F Feliu
Journal:  Drugs       Date:  1990       Impact factor: 9.546

3.  Assessment of Association between Antihypertensive Drug Use and Occurrence of New-onset Diabetes in South Indian Patients.

Authors:  Sneha M Sabu; Shubha Seshadri; Girish Thunga; Pooja G Poojari; Leelavathi D Acharya
Journal:  J Pharm Bioallied Sci       Date:  2020-01-29

Review 4.  Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.

Authors:  Rhonda M Cooper-DeHoff; Michael A Pacanowski; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

Review 5.  Adverse metabolic effects of antihypertensive drugs. Implications for treatment.

Authors:  H G Preuss; J F Burris
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

Review 6.  Pharmacology of stone disease.

Authors:  Khashayar Sakhaee
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

Review 7.  The role of dietary potassium in hypertension and diabetes.

Authors:  Cem Ekmekcioglu; Ibrahim Elmadfa; Alexa L Meyer; Thomas Moeslinger
Journal:  J Physiol Biochem       Date:  2015-12-03       Impact factor: 4.158

8.  Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients.

Authors:  Yong Hoon Kim; Ae-Young Her; Seung-Woon Rha; Byoung Geol Choi; Se Yeon Choi; Jae Kyeong Byun; Dong Oh Kang; Won Young Jang; Woohyeun Kim; Ju Yeol Baek; Woong Gil Choi; Tae Soo Kang; Jihun Ahn; Sang-Ho Park; Sung Hun Park; Ji Yeon Hong; Ji Young Park; Min-Ho Lee; Cheol Ung Choi; Chang Gyu Park; Hong Seog Seo
Journal:  J Diabetes Metab Disord       Date:  2020-04-03

9.  Calcium channel blocker monotherapy versus combination with renin-angiotensin system inhibitors on the development of new-onset diabetes mellitus in hypertensive Korean patients.

Authors:  Yong Hoon Kim; Ae-Young Her; Seung-Woon Rha; Byoung Geol Choi; Se Yeon Choi; Jae Kyeong Byun; Yoonjee Park; Dong Oh Kang; Won Young Jang; Woohyeun Kim; Woong Gil Choi; Tae Soo Kang; Jihun Ahn; Sang-Ho Park; Ji Young Park; Min-Ho Lee; Cheol Ung Choi; Chang Gyu Park; Hong Seog Seo
Journal:  J Geriatr Cardiol       Date:  2019-06       Impact factor: 3.327

10.  Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.

Authors:  J L Del-Aguila; A L Beitelshees; R M Cooper-Dehoff; A B Chapman; J G Gums; K Bailey; Y Gong; S T Turner; J A Johnson; E Boerwinkle
Journal:  Pharmacogenomics J       Date:  2013-02-12       Impact factor: 3.550
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.